GMP Small molecules for Antibody-drug Conjugate(ADC)

  • Product Quality Assurance
  • FDA DMF Filing
  • GMP Molecules for ADC
  • Slogan Icon ADC-Related Small Molecules
  • Slogan Icon High Purity
  • Slogan Icon Batch to Batch Consistency
  • Slogan Icon DMF Filing

The Antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy.

Product Quality Assurance

The MedChemExpress (MCE) GMP ADC-related small molecules are synthesized following ICH Q7 guidelines. Each batch of MedChemExpress (MCE) GMP small molecules has strict QC tests:
  • Purity

  • Identification

  • Water Content

  • Enantiomeric Impurity (If applicable)

  • Residual Solvent

  • Analysis of Impurities

  • Solubility

  • Others

FDA DMF Filing

MCE provides GMP ADC related small molecule products, and some products have already completed DMF filing, which is helpful for the development of related ADC drugs.
Name CAS Type FDA DMF Filing status
MC-Val-Cit-PAB 159857-80-4 Intermediate of MC-Val-Cit-PAB-MMAE Sec-DMF#035550
Boc-Dap-NE 160800-65-7 Intermediate of MMAE Sec-DMF#035548
Fmoc-3VVD-OH 863971-44-2 Intermediate of MMAE Sec-DMF#035549
VcMMAE 646502-53-6 Linker+Payload Sec-DMF#036740
Exatecan Mesylate 169869-90-3 Payload Sec-DMF#036708
By Targets:
Show More (8)
By Research Areas: